Inhibitors of Alzheimer’s BACE-1 with 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridine structure
- 424 Downloads
β-site amyloid precursor protein cleaving enzyme (BACE-1) is a validated target for Alzheimer therapy due to its distinctive role in pathogenesis of AD. In the present contribution, a series of new 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridine structures were synthesized as BACE-1 inhibitors (6a–6n). In vitro BACE-1 inhibitory activities were determined by enzymatic fluorescence resonance energy transfer assay. Synthesized dihydropyridine (DHP) analogues exhibited weak to good inhibitory activities while 6i, 6n and 6a were found to be the most potent molecules with 83.76, 79.45 and 72.47 % BACE-1 inhibition at 10 μM, respectively. Structure binding/activity relationship elucidations revealed that superior BACE-1 inhibitory activities were observed for DHP derivatives bearing fused/non-fused thiazole groups and particularly 3,5-bis-N-(6-ethoxy-2-benzothiazolyl) moiety. Binding maps showed that enhanced activity may be attributed to the additional H-bond and hydrophobic interactions with S2–S3 subpockets of BACE-1.
KeywordsAlzheimer BACE-1 Inhibition Dihydropyridine
This work was financially supported by research council of Shiraz University of Medical Sciences.
- Razzaghi-Asl, N., O. Firuzi, B. Hemmateenejad, K. Javidnia, N. Edraki, and R. Miri. 2013. Design and synthesis of Novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors. Bioorganic and Medicinal Chemistry 21(22): 6893–6909.CrossRefPubMedGoogle Scholar
- Sellers, R.P., L.D. Alexander, V.A. Johnson, C.C. Lin, J. Savage, R. Corral, J.T. Moss, S. Slugocki, E.K. Singh, and M.R. Davis. 2010. Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives. Bioorganic and Medicinal Chemistry Letter 18: 6822–6856.CrossRefGoogle Scholar
- Yan, R., M.J. Bienkowski, M.E. Shuck, H. Miao, M.C. Tory, A.M. Pauley, J.R. Brashler, N.C. Stratman, W.R. Mathews, A.E. Buhl, D.B. Carter, A.G. Tomasselli, L.A. Parodi, R.L. Heinrikson, and M.E. Gurney. 1999. Membrane-anchored aspartyl protease with Alzheimer’s disease [beta]-secretase activity. Nature 402: 533–537.CrossRefPubMedGoogle Scholar